Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Institutes of Health (RO1 CA247763)
National Institutes of Health (R21 CA238953)
National Institutes of Health (P01 CA217798)
DOD Prostate Cancer Research Program (PC200160)
- License Information
-
More Information
Article History
Received: 23 December 2021
Revised: 18 February 2022
Accepted: 7 March 2022
First Online: 29 April 2022
Declarations
:
: SKB is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc. The other authors declare no competing interests.
: Not applicable.
: Not applicable.
